Full-Time
RTR Accountant
Month FTC
Posted on 8/12/2025
FMC Corporation
5,001-10,000 employees
Develops herbicides, insecticides, and fungicides
No salary listed
Cork, Ireland
In Person
 Accounting (1) |
|---|
- Bachelor’s degree in Finance, Accounting, or equivalent.
- Strong analytical, problem-solving, and interpersonal skills.
- Ability to work collaboratively in a team-oriented environment.
- Proficiency in Excel and Word.
- Process journal entries, accruals, and adjustments in line with financial standards.
- Complete reconciliations and general ledger maintenance for business units.
- Execute month-end and quarter-end closing activities, ensuring accuracy and timeliness.
- Prepare and submit financial results to Corporate Accounting.
- Maintain compliance with US GAAP, local GAAP, SOX, and other regulatory requirements.
- Conduct bank account reconciliations and select treasury activities.
- Work closely with internal teams to resolve accounting issues and drive best practices.
- Support continuous improvement initiatives to enhance efficiency and standardization.
- Professional qualification (CPA, CFA, CIMA, ACCA, ACA) preferred.
- Prior experience in Record to Report (R2R) or accounting within a shared service centre is a plus.
- Proficiency in ERP systems (preferably SAP).
- Proficiency in Excel and Word.
FMC Corporation focuses on improving agriculture through science-based solutions. It develops and provides herbicides, insecticides, and fungicides, along with product formulations and technologies, to protect crops from pests and diseases while aiming to minimize environmental impact. The way FMC’s products work is by delivering active ingredients through formulations that enhance efficacy and safety, helping farmers protect yields and manage pests in a sustainable way. What sets FMC apart is its long history and explicit commitment to sustainable technologies and environmental protection, along with ongoing research to discover new active ingredients and smarter formulations. The company's overarching goal is to help farmers feed a growing global population by delivering science-driven agricultural solutions that safeguard crops and protect the planet.
Company Size
5,001-10,000
Company Stage
IPO
Headquarters
Philadelphia, Pennsylvania
Founded
1883
Simplify's Take
What believers are saying
- Management reaffirmed 2026 sales guidance of $3.6 billion to $3.8 billion.
- The $252 million India sale and $750 million notes support debt reduction.
- Project Foundation shifts production to lower-cost sites, improving margins through 2026.
What critics are saying
- Crop protection pricing remains weak, with Q1 2026 revenue down 4% year over year.
- Tighter covenants and pledged collateral reduce FMC's financial flexibility immediately.
- About $4.5 billion of debt against roughly $850 million EBITDA creates refinancing strain.
What makes FMC Corporation unique
- FMC sells proprietary active ingredients, not commoditized seeds or generic chemicals.
- Isoflex gained EU approval on April 6, 2026, widening European herbicide access.
- Three newest molecules generated about $200 million in 2025, proving pipeline traction.
Help us improve and share your feedback! Did you find this helpful?
Your Connections
People at FMC Corporation who can refer or advise you
Benefits
Professional Development Budget
Family Planning Benefits
Mental Health Support
Company News
FMC Corporation shares climbed 6.66% on Monday to close at $16.81, extending its winning streak to seven consecutive days. The rally came as investors positioned ahead of the company's dividend cutoff date and upcoming earnings release. FMC will distribute 8 cents per share to shareholders of record as of 31st March, payable on 16th April. The company is scheduled to report first-quarter results after market close on 29th April. For the first quarter, FMC expects revenues of $725 million to $775 million, excluding India operations, representing a 5% year-on-year decline. Adjusted EBITDA is forecast at $45 million to $55 million, down 54% to 62.5% from the prior year. For full-year 2026, the company targets revenues of $3.6 billion to $3.8 billion, with adjusted EBITDA of $670 million to $730 million.
FMC Corporation, an agricultural sciences company, has emerged as a potential deep-value opportunity following an 83% dividend cut and severe sell-off driven by agricultural demand weakness and pricing pressures. Trading at $16.02 with a forward P/E of 7.18, the stock reflects significant market pessimism. Despite third-quarter 2025 revenue declining materially, adjusted earnings improved year-over-year through cost controls and favourable product mix. However, the company faces substantial balance sheet risk with approximately $4.5 billion in debt against expected EBITDA of $850 million, pushing leverage above 5×. Management is prioritising debt reduction through potential divestitures, including its India business, whilst maintaining investment in new active ingredients and biological products. The investment case depends on agricultural cycle recovery and successful deleveraging execution. Hedge fund ownership declined from 43 to 35 funds in the third quarter.
Funding will help further build out the Agrospheres platform, which manufactures, encapsulates and delivers biological pesticides.
Micropep Technologies (Micropep), the global leader in micropeptide technology, today announced a $29 million Series B funding round along with its pr
CHARLOTTESVILLE, Va. November 27, 2023 – AgroSpheres, a biotechnology company pioneering breakthroughs in sustainable crop protection, today announced the closing of its Series B funding round with a strategic investment from FMC Corporation (NYSE: FMC), a global leader in agriculture sciences. This investment brings the total funding in AgroSpheres’ Series B round to $25 million, demonstrating the strong confidence in the company’s innovative solutions. FMC Ventures joins Lewis and Clark AgriFood, Ospraie Ag Science, BIDRA Ventures, and Cavallo Ventures to close out the round.